Reviewed by the Help Dementia Editorial Team — our editors review every article for accuracy against guidance from the National Institute on Aging, the Alzheimer’s Association, and peer-reviewed sources.
Dementia screening sits at the center of this dementia and brain health question.
Yes, dementia screening can—and increasingly should—become part of annual checkups, though substantial work remains to make this standard practice. Several major medical organizations, including the American Academy of Family Physicians and the American Geriatrics Society, now recommend that primary care doctors screen for cognitive impairment during routine visits. However, despite these guidelines, most Americans are not receiving any dementia screening in their doctor’s office, leaving early cognitive changes undetected when intervention is most effective.
The gap between what experts recommend and what actually happens in clinical practice reveals both the potential and the obstacles in making cognitive screening truly routine. A real-world example shows what’s possible: Geisinger Health System, a large integrated health network in Pennsylvania, piloted a dementia screening program within their annual wellness visits for Medicare patients. They implemented brief cognitive assessments using validated tools and found that integrating screening into existing preventive care visits was feasible and identified previously undiagnosed mild cognitive impairment in significant numbers. Yet even in health systems with the resources and commitment to implement such programs, barriers like time constraints, reimbursement uncertainty, and variable provider training continue to slow adoption.
Table of Contents
- Why Dementia Screening During Routine Check-ups Makes Clinical Sense
- Practical Screening Tools That Fit into Office Visits
- Integration with Existing Annual Wellness Benefit
- Overcoming Time and Workflow Barriers
- Concerns About False Positives, Anxiety, and Labeling
- What Happens After Screening?
- The Future: Moving Toward Integrated Brain Health in Primary Care
- Conclusion
Why Dementia Screening During Routine Check-ups Makes Clinical Sense
Early detection of cognitive decline offers a genuine window of opportunity for intervention. When mild cognitive impairment or early dementia is identified during an annual checkup—when the patient and doctor are already together and focused on health—there’s time to explore causes, modify risk factors, and plan for future care. A 65-year-old seeing her doctor for her annual physical might have subtle memory issues she’s dismissed as normal aging, but formal screening could reveal treatable causes like vitamin B12 deficiency, thyroid dysfunction, or medication side effects that mimic dementia.
Cognitively screening everyone in the primary care setting also captures people who might never seek specialist neuropsychology evaluations on their own. Many people with early memory problems either don’t recognize the problem or feel embarrassed to bring it up. When a doctor initiates the conversation through a brief screening test, it normalizes the discussion and removes the stigma. The earlier detection enables lifestyle interventions—cognitive training, exercise programs, cardiovascular risk management—that have evidence supporting benefit in slowing cognitive decline, particularly in people with mild cognitive impairment.
Practical Screening Tools That Fit into Office Visits
Several validated screening tools exist that take only five to fifteen minutes to administer, making them feasible for a busy primary care practice. The Montreal cognitive Assessment (MoCA) is popular but requires training and takes about 10-15 minutes. The Mini-Cog takes just 3-5 minutes and consists of a simple three-word recall test combined with a clock-drawing task; it has decent sensitivity and specificity for detecting cognitive impairment. The GPCOG (General Practitioner Assessment of Cognition) is another brief option designed specifically for primary care use. However, a major limitation exists: many primary care providers receive little to no training in administering or interpreting these tools.
Without proper training, even a simple screening test can produce false results, and inadequate interpretation may lead to unnecessary specialist referrals or, conversely, missed cases. Another practical consideration is who should be screened. Screening everyone starting at age 65 would be comprehensive but resource-intensive. Many guidelines suggest beginning screening at age 65 or 75, or screening symptomatic patients and those with risk factors like diabetes, hypertension, or a family history of dementia. The challenge is deciding these criteria consistently across different practices. A 68-year-old with controlled blood pressure and no concerning symptoms might be screened by one doctor and not by another, creating inequitable access to early detection.
Integration with Existing Annual Wellness Benefit
Medicare covers an Annual Wellness Visit that includes a cognitive assessment, which provides an existing infrastructure for dementia screening. In theory, primary care doctors could use this visit to administer brief cognitive screening to all eligible beneficiaries. Some practices have successfully integrated cognitive screening into this visit, typically using a two-stage approach: everyone gets a brief screening test, and those who score below cutoff are referred for further evaluation. This model makes sense operationally because the visit is already funded and scheduled.
However, the reality shows significant gaps. Many Medicare beneficiaries don’t use their annual wellness visit, and among those who do, not all practices remember to conduct cognitive screening. Training clinicians and support staff to administer and interpret screening tools requires time and resources. Practices may also worry about liability—if screening identifies potential cognitive impairment, does the practice have an obligation to refer for specialist evaluation? Without clear liability frameworks, some providers prefer not to screen rather than navigate unclear clinical and legal territory.
Overcoming Time and Workflow Barriers
The primary obstacle to routine dementia screening in primary care is time. A typical primary care visit lasts 15-20 minutes, and primary care doctors manage multiple chronic diseases, medication management, and preventive care. Adding a 5- to 15-minute cognitive screening can feel like an unwelcome burden, especially if the doctor is already pressed for time.
Practices that have successfully implemented screening typically use a team-based approach where trained medical assistants or nurse practitioners administer the screening test, not the physician, freeing the doctor to focus on interpretation and next steps. Another approach is using self-administered digital screening tools during the waiting period before the visit or in the exam room. Patients can complete a computerized cognitive assessment while waiting, and the results are available for the doctor to review before the patient visit. This solves the time problem but introduces another: not all patients are equally comfortable with technology, and digital versions of cognitive tests may introduce new sources of error or bias.
Concerns About False Positives, Anxiety, and Labeling
Cognitive screening tests, while useful, are not perfectly accurate. A concerning finding is that false positive rates for some screening tools can be substantial, particularly in people with depression, anxiety, poor sleep, or low education. An 72-year-old woman screened in her annual visit might score below the cutoff on a cognitive test simply because she was anxious about the test or because her hearing difficulty made her unable to hear instructions clearly—not because she has genuine cognitive impairment. Following up a false positive with additional testing and specialist evaluation creates unnecessary stress and healthcare costs.
There’s also the worry of labeling. Once someone receives a diagnosis of mild cognitive impairment or early dementia, that label can affect their self-perception, relationships, and ability to access credit or insurance. Even an intermediate result—”your screening suggests possible cognitive changes that need further evaluation”—can trigger anxiety and worry. Some patients may not want to know about subtle cognitive changes if no effective treatment is available, making the ethical case for universal screening less clear-cut.
What Happens After Screening?
If screening identifies possible cognitive impairment during an annual checkup, the next steps matter enormously. Ideally, a referral pathway exists to neurologists, neuropsychologists, or memory care clinics for comprehensive evaluation. However, access to specialists varies dramatically by geography and insurance.
A patient in a major metropolitan area might be able to see a neuropsychologist within a month; a patient in a rural area might wait six months or might not have access to specialist evaluation at all. Without clear referral pathways and affordable specialist access, screening becomes frustrating—the test identifies a possible problem, but the system cannot deliver diagnosis and care. Additionally, primary care doctors need guidance on how to manage the screening results. What do they tell a patient who scores on the borderline? Should they repeat screening in six months? Should they start certain medications or supplements? Most primary care doctors don’t have specialized dementia knowledge, so without clear protocols and support from specialists, they may feel uncertain how to respond to screening results.
The Future: Moving Toward Integrated Brain Health in Primary Care
The momentum toward routine cognitive screening is real, driven by major medical societies, recognition of the importance of early detection, and the availability of practical screening tools. As Medicare expands coverage for amyloid PET imaging and tau biomarkers for people with cognitive impairment, and as disease-modifying therapies like lecanemab (Leqembi) gain broader use, the case for earlier detection in primary care becomes stronger.
Early detection enables earlier diagnosis and access to these interventions, potentially preserving cognition and functional independence longer. Looking forward, successful integration of dementia screening into primary care will likely require systemic changes: training programs for primary care providers in cognitive assessment, clear referral pathways to specialists, reimbursement models that fairly compensate for screening and follow-up, and digital tools that reduce administrative burden. Some health systems are already moving in this direction, recognizing that a comprehensive approach to brain health in primary care—one that includes cognitive screening, cardiovascular risk management, sleep assessment, and cognitive engagement—makes sense both clinically and practically.
Conclusion
Dementia screening is feasible and beneficial in annual checkups, and movement toward this practice is already underway in forward-thinking health systems. The clinical case is sound: early detection of cognitive decline allows time for intervention, investigation of reversible causes, and informed planning. However, making this screening truly routine—available to all patients consistently, with proper training, clear interpretation, and functional referral pathways—remains a significant undertaking that requires buy-in from primary care practices, specialists, health systems, and payers.
If you’re approaching an annual checkup and want cognitive screening as part of your visit, discuss this directly with your primary care doctor. If you’ve noticed cognitive changes in yourself or a family member, bring this up during routine visits rather than waiting for the provider to initiate screening. As the healthcare system gradually integrates dementia screening into standard preventive care, informed patients who advocate for this assessment will help move the practice forward.
You Might Also Like
- Can Physical Therapy Help Dementia Patients Stay Mobile?
- Can Dementia Research Help Families Now?
- Can Dementia Drugs Work Better With Lifestyle Changes?
For more, see Alzheimer’s Association — caregiving.
